The expression of the tetraspanin CD9, responsible for the maintenance of glioblastoma-like stem cells [32], and of CD81, associated with enhanced resistance to radiotherapy [33], is increased in low-grade gliomas and glioblastoma, respectively. Here, CD9 is linked to central nervous system cancer.